Literature DB >> 1868878

Effects of trimebutine on cytosolic Ca2+ and force transitions in intestinal smooth muscle.

M Nagasaki1, T Kobayashi, H Tamaki.   

Abstract

The effects of trimebutine maleate on cytosolic free Ca2+ and force transitions in the guinea-pig taenia cecum were studied by fura-2 fluorometry and tension recording. The addition of 80 mM K+ induced a transient increase in cytosolic free Ca2+ concentration ([Ca2+]i) and tension, followed by a sustained increase. Trimebutine (10 microM) suppressed both [Ca2+]i elevation and tension development. The tonic responses were more potently inhibited than the phasic responses. Phasic components gradually increased as the added K+ increased (10-40 mM). The relationship between the peak increases in [Ca2+]i and tension was not affected by trimebutine (10 microM). This means that trimebutine does not affect the Ca2+ sensitivity of contractile elements. In a high K+ and Ca(2+)-free medium, carbachol (10 microM) or caffeine (30 mM) caused transient [Ca2+]i elevation and tension development in the smooth muscle. Trimebutine (10 microM) decreased the amplitude of both responses. Trimebutine (10 microM) inhibited the spontaneous fluctuations in [Ca2+]i and motility of taenia cecum in the presence of tetrodotoxin (TTX; 0.3 microM). These results suggest that trimebutine has two types of inhibitory actions on intestinal smooth muscle; one, the inhibition of Ca2+ influx through voltage-dependent calcium channels, and the other, the inhibition of Ca2+ release from intracellular storage sites.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1868878     DOI: 10.1016/0014-2999(91)90471-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Effect of trimebutine on voltage-activated calcium current in rabbit ileal smooth muscle cells.

Authors:  M Nagasaki; S Komori; H Ohashi
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

2.  Trimebutine Promotes Glioma Cell Apoptosis as a Potential Anti-tumor Agent.

Authors:  Yi-Pu Fan; Pei Liu; Wei-Kang Xue; Wei-Jiang Zhao; Hong-Chao Pan
Journal:  Front Pharmacol       Date:  2018-06-21       Impact factor: 5.810

3.  Repositioning Trimebutine Maleate as a Cancer Treatment Targeting Ovarian Cancer Stem Cells.

Authors:  Heejin Lee; Oh-Bin Kwon; Jae-Eon Lee; Yong-Hyun Jeon; Dong-Seok Lee; Sang-Hyun Min; Jun-Woo Kim
Journal:  Cells       Date:  2021-04-16       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.